Myricetin, a natural inhibitor of CD147, increases sensitivity of cisplatin in ovarian cancer
.
Source: Expert Opinion on Therapeutic Targets - Category: Drugs & Pharmacology Authors: Lin ChenTian FanMiao WangChun-Yu ZhuWang-You FengYu LiHong Yanga Department of Obstetrics and Gynecology, Xijing Hospital, Fourth Military Medical University, Xi ’an, Chinab Laboratory of Cell Biology, Institute of Medical Research, Northwestern Polytec Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Cytology | Drugs & Pharmacology | Hospitals | Laboratory Medicine | OBGYN | Ovarian Cancer | Ovaries | Research